JUVÉDERM® holds a leading position among hyaluronic acid injectable fillers worldwide.*,1
Our full range of hyaluronic acid facial fillers is built on Allergan’s Aesthetics, a division of AbbVie, heritage of quality, science and meaningful innovation.2-9
Thanks to JUVÉDERM®’s patented technology,10,11 each gel is carefully designed with specific properties to address the different needs of each area of the face.2-9
* Based on HCP tracking market research, from over 1,700 HCPs from 16 international markets.1
1. Allergan Aesthetics. Data on File. REF-108642. Juvéderm®, the world’s leading brand of hyaluronic acid facial fillers. Mar 2023.
2. Juvéderm® VOLBELLA with lidocaine DFU. 73363JS10. Revision 2020-07-10.
3. Juvéderm® VOLIFT with lidocaine DFU. 73652JT10. Revision 2019-09-09.
4. Juvéderm® VOLUMA with lidocaine DFU. 73650JT10. Revision 2019-09-09.
5. Juvéderm® VOLUX DFU. 73651JT10. Revision 2019-09-09.
6. Juvéderm® ULTRA 2 DFU. 73661JT10. Revision 2019-09-09.
7. Juvéderm® ULTRA 3 DFU. 73662JT10. Revision 2019-09-09.
8. Juvéderm® ULTRA 4 DFU. 73663JT10. Revision 2019-09-09.
9. Juvéderm® ULTRA SMILE with lidocaine DFU. 73664JT10.Revision 2019-09-09.
10. Goodman GJ et al. Plast Reconstr Surg. 2015;136:S139–48.
11. Lebreton P. 2004. WO2004092222A2. Cross linking of low and high molecular weight polysaccharides preparation of injectable monophase hydrogels and polysaccharides and hydrogels thus obtained. Available at: http:/patents.google.com/patent/WO2004092222A2/en. [Accessed December 2025].
* The products are intended for professional use only.
Hyaluronic acid gel (24mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 0.55mL
Hyaluronic acid gel (24mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (24mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (24mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 0.55mL
Hyaluronic acid gel (15mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (17,5mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (17,5mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 0.55mL
Hyaluronic acid gel (20mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (25mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Report an Adverse Event
Adverse Events must be reported to AbbVie (tel: 2144165555, email: greekpv@abbvie.com) and
For events from the use of a medical device, for Greece: tel. 2132040528/542 or visit the website: https://www.eof.gr/ web/ guest/ whitegeneral or via email at: vigilancematerial@eof.gr, and for Cyprus: tel. 22 605785/735/572 or via email at: cymda@mphs.moh.gov.cy.